Research graph
References from Cáncer de mama de buen pronóstico en pacientes de edad avanzada: ¿está aún justificada la biopsia del ganglio centinela?. Local targets link to admitted publications; unresolved targets remain external evidence.
Omission of sentinel node biopsy for breast cancer: Historical context and future perspectives on a modern controversy
10.1002/cncr.33960 · 2021 · External reference
Use of sentinel lymph node biopsy in elderly patients with breast cancer – 10-year experience from a Swiss university hospital
10.1186/s12957-023-03062-1 · 2023 · External reference
Twenty-five-year follow-up of a randomized trial comparing radical mastectomy total mastectomy, and total mastectomy followed by irradiation
10.1056/nejmoa020128 · 2002 · External reference
Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer: 10-year results of the randomized controlled EORTC 10981-22023 AMAROS trial
10.1200/jco.22.01565 · 2023 · External reference
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial
10.1016/s1470-2045(18)30380-2 · 2018 · External reference
Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial
10.1001/jama.2017.11470 · 2017 · External reference
Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial
10.1001/jama.2013.278932 · 2013 · External reference
The impact of genomic profiling on adjuvant therapy recommendation in postmenopausal women with ER-positive, T1-2 breast cancer: can genomic profiling eliminate the need for sentinel lymph node biopsy?
10.1016/j.clbc.2021.02.011 · 2021 · External reference
De-escalating axillary surgery in early-stage breast cancer
10.1016/j.breast.2021.11.018 · 2022 · External reference
Cost-effectiveness analyses demonstrate that observation is superior to sentinel lymph node biopsy for postmenopausal women with HR+ breast cancer and negative axillary ultrasound
10.1007/s10549-020-05768-2 · 2020 · External reference
Impact of sentinel lymph node biopsy on management of older women with clinically node-negative, early-stage, ER+/HER2− invasive breast cancer: a systematic review and meta-analysis
10.1016/j.clbc.2024.07.012 · 2024 · External reference
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate helath care interventions: explanation and elaboration
2009 · External reference
Prevalence of pathologic N2/N3 disease in postmenopausal women with clinical N0 ER+/HER2− breast cancer
10.1245/s10434-022-12056-4 · 2022 · External reference
Nodal positivity decreases with age in women with early-stage, hormone receptor-positive breast cancer
10.1002/cncr.32668 · 2020 · External reference
Axillary staging is not justified in postmenopausal clinically node-negative women based on nodal disease burden
10.1245/s10434-022-12203-x · 2023 · External reference
The role of routine sentinel lymph node biopsy in elderly patients with breast cancer
10.1016/j.ejso.2022.03.094 · 2022 · External reference
Abstract P2-14-07: Omission of sentinel lymph node biopsy in patients with early stage breast cancer: looking beyond the choosing wisely guidelines for age<70
2023 · External reference
Sentinel lymph node biopsy vs no axillary surgery in patients with small breast cancer and negative results on ultrasonography of axillary lymph nodes: the sound randomized clinical trial
10.1001/jamaoncol.2023.3759 · 2023 · External reference
Axillary surgery in breast cancer - Primary results of the INSEMA trial
10.1056/nejmoa2412063 · 2025 · External reference
Omitting radiotherapy is safe in breast cancer patients≥70 years old after breast-conserving surgery without axillary lymph node operation
10.1038/s41598-020-76663-5 · 2020 · External reference
Omission of radiotherapy in women>60 years old after breast conserving surgery for breast cancer is non-inferior in terms of local recurrence: a retrospective cohort study
10.4274/ejbh.galenos.2023.2023-9-5 · 2024 · External reference
Long-term outcome of pT1a-b, cN0 breast cancer without axillary dissection or staging: a prospective observational study of 1543 women
10.1002/bjs.11610 · 2020 · External reference
Outcomes after sentinel lymph node biopsy and radiotherapy in older women with early-stage estrogen receptor-positive breast cancer
10.1001/jamanetworkopen.2021.6322 · 2021 · External reference
Nodal staging affects adjuvant treatment choices in elderly patients with clinically node-negative estrogen receptor-positive breast cancer
10.3747/co.27.6515 · 2020 · External reference
Can we successfully de-escalate axillary surgery in women aged≥70 years with ductal carcinoma in situ or early-stage breast cancer undergoing mastectomy?
10.1245/s10434-021-11140-5 · 2022 · External reference
The role of sentinel lymph node biopsy in planning adjuvant therapy for elderly women with low-risk breast cancer
10.1111/tbj.13577 · 2020 · External reference
O79: The role of sentinel lymph node biopsy in breast cancer patients over the age of 80 – How much is enough?
2021 · External reference
Impact of sentinel lymph node biopsy on treatment decision and survival in patients aged≥70 years with breast cancer: a retrospective study
10.1177/15330338221137216 · 2022 · External reference
(P05) Does sentinel lymph node biopsy impact systemic therapy recommendations?
10.1016/j.ijrobp.2018.02.093 · 2018 · External reference
Does sentinel lymph node biopsy influence subsequent management decisions in women with breast cancer≥70 years old?
10.1016/j.clbc.2024.05.002 · 2024 · External reference
Is it wise to omit sentinel node biopsy in elderly patients with breast cancer?
10.1245/s10434-020-08759-1 · 2021 · External reference
The association between surgical axillary staging adjuvant treatment use and survival in older women with early stage breast cancer: a population-based study
10.1245/s10434-023-13274-0 · 2023 · External reference
Minimal prognostic significance of sentinel lymph node metastasis in patients with cT1-2 and cN0 breast cancer
10.1186/s12957-019-1585-9 · 2019 · External reference
Is surgical axillary staging necessary in women with T1 breast cancer who are treated with breast-conserving therapy?
10.1186/s40880-019-0371-y · 2019 · External reference
Sentinel node biopsy should not be routine in older patients with ER-positive HER2-negative breast cancer who are willing and able to take hormone therapy
10.1245/s10434-021-09839-6 · 2021 · External reference
Not performing a sentinel node biopsy for older patients with early-stage invasive breast cancer
10.1001/jamasurg.2015.0647 · 2015 · External reference
Predicting survival benefit of sparing sentinel lymph node biopsy in low-risk elderly patients with early breast cancer: a population-based analysis
2020 · External reference
Luminal A versus B after choosing wisely: does lymph node surgery affect oncologic outcomes?
10.1245/s10434-023-14485-1 · 2024 · External reference
Long-term outcome and axillary recurrence in elderly women (≥70 years) with breast cancer: 10-years follow-up from a matched cohort study
10.1016/j.ejso.2021.02.027 · 2021 · External reference
A prospective study of sentinel node biopsy omission in women age≥65 years with ER+ breast cancer
10.1245/s10434-024-15000-w · 2024 · External reference
Omission of axillary staging in elderly patients with early stage breast cancer impacts regional control but not survival: a systematic review and meta-analysis
10.1016/j.jgo.2016.12.003 · 2017 · External reference
Long-term oncologic outcomes after omitting axillary surgery in older women with early stage, node-negative breast cancer: a systematic review and meta-analysis
2023 · External reference
Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013-08)
10.1186/s12885-017-3443-x · 2017 · External reference
Feasibility of sentinel lymph node biopsy omission after integration of 18F-FDG dedicated lymph node PET in early breast cancer: a prospective phase ii trial
10.20892/j.issn.2095-3941.2022.0085 · 2022 · External reference
No axillary surgical treatment for lymph node-negative patients after ultra-sonography [NAUTILUS]: protocol of a prospective randomized clinical trial
10.1186/s12885-022-09273-1 · 2022 · External reference
Unresolved reference
External reference
How often do sentinel lymph node biopsy results affect adjuvant therapy decisions among postmenopausal women with early-stage HR+/HER2− breast cancer in the post-RxPONDER era?
10.1245/s10434-022-12193-w · 2022 · External reference
Is axillary staging obsolete in early breast cancer?
10.1016/j.soc.2023.05.002 · 2023 · External reference
21-gene assay to inform chemotherapy benefit in node-positive breast cancer
10.1056/nejmoa2108873 · 2021 · External reference
Clinical outcomes in early breast cancer with a high 21-gene recurrence score of 26 to 100 assigned to adjuvant chemotherapy plus endocrine therapy: a secondary analysis of the TAILORx randomized clinical trial
10.1001/jamaoncol.2019.4794 · 2020 · External reference
Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343
10.1200/jco.2012.45.2615 · 2013 · External reference
Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial
10.1016/s1470-2045(14)71221-5 · 2015 · External reference
Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93
10.1200/jco.2005.01.5784 · 2006 · External reference
Axillary lymph node dissection versus no dissection in patients with T1N0 breast cancer: a randomized clinical trial (INT09/98)
10.1002/cncr.28499 · 2014 · External reference
Unresolved reference
External reference
A scoping review characterizing “Choosing Wisely®” recommendations for breast cancer management
10.1007/s10549-020-06009-2 · 2021 · External reference
Shoulder and arm morbidity in sentinel node-negative breast cancer patients: a systematic review
10.1007/s10549-014-2846-5 · 2014 · External reference
Trends in breast cancer treatment de-implementation in older patients with hormone receptor-positive breast cancer: a mixed methods study
10.1245/s10434-020-08823-w · 2021 · External reference
Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial
10.1016/s1470-2045(14)70460-7 · 2014 · External reference
Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial
10.1001/jama.2013.278932 · ExternalCitation · doi-reference
Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial
10.1001/jama.2017.11470 · ExternalCitation · doi-reference
Outcomes after sentinel lymph node biopsy and radiotherapy in older women with early-stage estrogen receptor-positive breast cancer
10.1001/jamanetworkopen.2021.6322 · ExternalCitation · doi-reference
Clinical outcomes in early breast cancer with a high 21-gene recurrence score of 26 to 100 assigned to adjuvant chemotherapy plus endocrine therapy: a secondary analysis of the TAILORx randomized clinical trial
10.1001/jamaoncol.2019.4794 · ExternalCitation · doi-reference
Sentinel lymph node biopsy vs no axillary surgery in patients with small breast cancer and negative results on ultrasonography of axillary lymph nodes: the sound randomized clinical trial
10.1001/jamaoncol.2023.3759 · ExternalCitation · doi-reference
Not performing a sentinel node biopsy for older patients with early-stage invasive breast cancer
10.1001/jamasurg.2015.0647 · ExternalCitation · doi-reference
Long-term outcome of pT1a-b, cN0 breast cancer without axillary dissection or staging: a prospective observational study of 1543 women
10.1002/bjs.11610 · ExternalCitation · doi-reference
Axillary lymph node dissection versus no dissection in patients with T1N0 breast cancer: a randomized clinical trial (INT09/98)
10.1002/cncr.28499 · ExternalCitation · doi-reference
Nodal positivity decreases with age in women with early-stage, hormone receptor-positive breast cancer
10.1002/cncr.32668 · ExternalCitation · doi-reference
Omission of sentinel node biopsy for breast cancer: Historical context and future perspectives on a modern controversy
10.1002/cncr.33960 · ExternalCitation · doi-reference
Shoulder and arm morbidity in sentinel node-negative breast cancer patients: a systematic review
10.1007/s10549-014-2846-5 · ExternalCitation · doi-reference
Cost-effectiveness analyses demonstrate that observation is superior to sentinel lymph node biopsy for postmenopausal women with HR+ breast cancer and negative axillary ultrasound
10.1007/s10549-020-05768-2 · ExternalCitation · doi-reference
A scoping review characterizing “Choosing Wisely®” recommendations for breast cancer management
10.1007/s10549-020-06009-2 · ExternalCitation · doi-reference
De-escalating axillary surgery in early-stage breast cancer
10.1016/j.breast.2021.11.018 · ExternalCitation · doi-reference
The impact of genomic profiling on adjuvant therapy recommendation in postmenopausal women with ER-positive, T1-2 breast cancer: can genomic profiling eliminate the need for sentinel lymph node biopsy?
10.1016/j.clbc.2021.02.011 · ExternalCitation · doi-reference
Does sentinel lymph node biopsy influence subsequent management decisions in women with breast cancer≥70 years old?
10.1016/j.clbc.2024.05.002 · ExternalCitation · doi-reference
Impact of sentinel lymph node biopsy on management of older women with clinically node-negative, early-stage, ER+/HER2− invasive breast cancer: a systematic review and meta-analysis
10.1016/j.clbc.2024.07.012 · ExternalCitation · doi-reference
Long-term outcome and axillary recurrence in elderly women (≥70 years) with breast cancer: 10-years follow-up from a matched cohort study
10.1016/j.ejso.2021.02.027 · ExternalCitation · doi-reference
The role of routine sentinel lymph node biopsy in elderly patients with breast cancer
10.1016/j.ejso.2022.03.094 · ExternalCitation · doi-reference
(P05) Does sentinel lymph node biopsy impact systemic therapy recommendations?
10.1016/j.ijrobp.2018.02.093 · ExternalCitation · doi-reference
Omission of axillary staging in elderly patients with early stage breast cancer impacts regional control but not survival: a systematic review and meta-analysis
10.1016/j.jgo.2016.12.003 · ExternalCitation · doi-reference
Is axillary staging obsolete in early breast cancer?
10.1016/j.soc.2023.05.002 · ExternalCitation · doi-reference
Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial
10.1016/s1470-2045(14)70460-7 · ExternalCitation · doi-reference
Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial
10.1016/s1470-2045(14)71221-5 · ExternalCitation · doi-reference
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial
10.1016/s1470-2045(18)30380-2 · ExternalCitation · doi-reference
Omitting radiotherapy is safe in breast cancer patients≥70 years old after breast-conserving surgery without axillary lymph node operation
10.1038/s41598-020-76663-5 · ExternalCitation · doi-reference
Twenty-five-year follow-up of a randomized trial comparing radical mastectomy total mastectomy, and total mastectomy followed by irradiation
10.1056/nejmoa020128 · ExternalCitation · doi-reference
21-gene assay to inform chemotherapy benefit in node-positive breast cancer
10.1056/nejmoa2108873 · ExternalCitation · doi-reference
Axillary surgery in breast cancer - Primary results of the INSEMA trial
10.1056/nejmoa2412063 · ExternalCitation · doi-reference
The role of sentinel lymph node biopsy in planning adjuvant therapy for elderly women with low-risk breast cancer
10.1111/tbj.13577 · ExternalCitation · doi-reference
Impact of sentinel lymph node biopsy on treatment decision and survival in patients aged≥70 years with breast cancer: a retrospective study
10.1177/15330338221137216 · ExternalCitation · doi-reference
Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013-08)
10.1186/s12885-017-3443-x · ExternalCitation · doi-reference
No axillary surgical treatment for lymph node-negative patients after ultra-sonography [NAUTILUS]: protocol of a prospective randomized clinical trial
10.1186/s12885-022-09273-1 · ExternalCitation · doi-reference
Minimal prognostic significance of sentinel lymph node metastasis in patients with cT1-2 and cN0 breast cancer
10.1186/s12957-019-1585-9 · ExternalCitation · doi-reference
Use of sentinel lymph node biopsy in elderly patients with breast cancer – 10-year experience from a Swiss university hospital
10.1186/s12957-023-03062-1 · ExternalCitation · doi-reference
Is surgical axillary staging necessary in women with T1 breast cancer who are treated with breast-conserving therapy?
10.1186/s40880-019-0371-y · ExternalCitation · doi-reference
Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93
10.1200/jco.2005.01.5784 · ExternalCitation · doi-reference
Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343
10.1200/jco.2012.45.2615 · ExternalCitation · doi-reference
Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer: 10-year results of the randomized controlled EORTC 10981-22023 AMAROS trial
10.1200/jco.22.01565 · ExternalCitation · doi-reference
Is it wise to omit sentinel node biopsy in elderly patients with breast cancer?
10.1245/s10434-020-08759-1 · ExternalCitation · doi-reference
Trends in breast cancer treatment de-implementation in older patients with hormone receptor-positive breast cancer: a mixed methods study
10.1245/s10434-020-08823-w · ExternalCitation · doi-reference
Sentinel node biopsy should not be routine in older patients with ER-positive HER2-negative breast cancer who are willing and able to take hormone therapy
10.1245/s10434-021-09839-6 · ExternalCitation · doi-reference
Can we successfully de-escalate axillary surgery in women aged≥70 years with ductal carcinoma in situ or early-stage breast cancer undergoing mastectomy?
10.1245/s10434-021-11140-5 · ExternalCitation · doi-reference
Prevalence of pathologic N2/N3 disease in postmenopausal women with clinical N0 ER+/HER2− breast cancer
10.1245/s10434-022-12056-4 · ExternalCitation · doi-reference
How often do sentinel lymph node biopsy results affect adjuvant therapy decisions among postmenopausal women with early-stage HR+/HER2− breast cancer in the post-RxPONDER era?
10.1245/s10434-022-12193-w · ExternalCitation · doi-reference
Axillary staging is not justified in postmenopausal clinically node-negative women based on nodal disease burden
10.1245/s10434-022-12203-x · ExternalCitation · doi-reference
The association between surgical axillary staging adjuvant treatment use and survival in older women with early stage breast cancer: a population-based study
10.1245/s10434-023-13274-0 · ExternalCitation · doi-reference
Luminal A versus B after choosing wisely: does lymph node surgery affect oncologic outcomes?
10.1245/s10434-023-14485-1 · ExternalCitation · doi-reference
A prospective study of sentinel node biopsy omission in women age≥65 years with ER+ breast cancer
10.1245/s10434-024-15000-w · ExternalCitation · doi-reference
Feasibility of sentinel lymph node biopsy omission after integration of 18F-FDG dedicated lymph node PET in early breast cancer: a prospective phase ii trial
10.20892/j.issn.2095-3941.2022.0085 · ExternalCitation · doi-reference
Nodal staging affects adjuvant treatment choices in elderly patients with clinically node-negative estrogen receptor-positive breast cancer
10.3747/co.27.6515 · ExternalCitation · doi-reference
Omission of radiotherapy in women>60 years old after breast conserving surgery for breast cancer is non-inferior in terms of local recurrence: a retrospective cohort study
10.4274/ejbh.galenos.2023.2023-9-5 · ExternalCitation · doi-reference
